Higenbottam TW - Search Results

1

Inhaled nitric oxide and arterial oxygen tension in patients with chronic obstructive pulmonary disease and severe pulmonary hypertension.

Katayama Y, Higenbottam TW, Diaz de Atauri MJ, Cremona G, Akamine S, Barbera JA, Rodrìguez-Roisin R. Katayama Y, et al. Among authors: higenbottam tw. Thorax. 1997 Feb;52(2):120-4. doi: 10.1136/thx.52.2.120. Thorax. 1997. PMID: 9059470 Free PMC article. Clinical Trial.

2

Minimizing the inhaled dose of NO with breath-by-breath delivery of spikes of concentrated gas.

Katayama Y, Higenbottam TW, Cremona G, Akamine S, Demoncheaux EA, Smith AP, Siddons TE. Katayama Y, et al. Among authors: higenbottam tw. Circulation. 1998 Dec 1;98(22):2429-32. doi: 10.1161/01.cir.98.22.2429. Circulation. 1998. PMID: 9832488 Clinical Trial.

3

Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity.

Cremona G, Higenbottam T, Borland C, Mist B. Cremona G, et al. QJM. 1994 Sep;87(9):547-51. QJM. 1994. PMID: 7953503

4

Acute and chronic hypoxic pulmonary hypertension.

Higenbottam T, Cremona G. Higenbottam T, et al. Eur Respir J. 1993 Sep;6(8):1207-12. Eur Respir J. 1993. PMID: 7693507 Review.

5

Endothelium-derived relaxing factor and the pulmonary circulation.

Cremona G, Dinh Xuan AT, Higenbottam TW. Cremona G, et al. Among authors: higenbottam tw. Lung. 1991;169(4):185-202. doi: 10.1007/BF02714154. Lung. 1991. PMID: 1921472 Review.

6

Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease.

Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J. Dinh-Xuan AT, et al. Among authors: higenbottam tw. N Engl J Med. 1991 May 30;324(22):1539-47. doi: 10.1056/NEJM199105303242203. N Engl J Med. 1991. PMID: 2027358 Free article.

7

Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to L-arginine deficiency.

Dinh-Xuan AT, Pepke-Zaba J, Butt AY, Cremona G, Higenbottam TW. Dinh-Xuan AT, et al. Among authors: higenbottam tw. Br J Pharmacol. 1993 Jun;109(2):587-91. doi: 10.1111/j.1476-5381.1993.tb13611.x. Br J Pharmacol. 1993. PMID: 7689396 Free PMC article.

8

In vitro pulmonary vasorelaxant effect of the phosphodiesterase inhibitor enoximone.

Butt AY, Dinh-Xuan AT, Pepke-Zaba J, Cremona G, Clelland CA, Higenbottam TW. Butt AY, et al. Among authors: higenbottam tw. Angiology. 1993 Apr;44(4):289-94. doi: 10.1177/000331979304400404. Angiology. 1993. PMID: 8457079

9

Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease.

Barberà JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Barberà JA, et al. Among authors: higenbottam tw. Lancet. 1996 Feb 17;347(8999):436-40. doi: 10.1016/s0140-6736(96)90011-2. Lancet. 1996. PMID: 8618485

10

Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome.

Cremona G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, Roe P, Jones GJ. Cremona G, et al. Among authors: higenbottam tw. Eur Respir J. 1995 Nov;8(11):1883-5. doi: 10.1183/09031936.95.08111883. Eur Respir J. 1995. PMID: 8620957 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters